Expertise in
2
conditions

Jean-pierre P. Vannier

Rouen, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
2
conditions
Rouen, FR 

Overview

Jean-pierre Vannier practices practicing medicine in Rouen, France.

Mr. Vannier is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Sideroblastic Anemia, Acute Lymphoblastic Leukemia (ALL), Leukemia, Anemia, and Bone Marrow Transplant.

He is actively involved in clinical research, co-authoring 45 peer reviewed articles and participating in 5 clinical trials.

Gender

Male

Locations

Rouen, 76000, France
Other Locations
CHU de Strasbourg
Strasbourg, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Enrollment Status: Recruiting
Publish Date: January 16, 2024
Intervention Type: Drug, Radiation
Study Drugs: VP16, Thiotepa, Treosulfan, Fludarabine, Busulfan, Anti-Thymocyte Globulin, Cyclophosphamide, Grafalon
Study Phase: Phase 2/Phase 3
Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated
Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated
Enrollment Status: Active_not_recruiting
Publish Date: January 07, 2026
Intervention Type: Procedure, Drug, Radiation, Other
Study Drugs: Etoposide, Vincristine, Carboplatin, Cyclophosphamide, Thiotepa
Study Phase: Phase 2
Conservative Treatments of Retinoblastoma
Conservative Treatments of Retinoblastoma
Enrollment Status: Active_not_recruiting
Publish Date: November 24, 2025
Intervention Type: Drug, Device, Radiation
Study Drugs: VP16, Carboplatin, Melphalan, VP16, Carboplatin, Vincristin, Carboplatin + Laser Day 1 (Chemothermotherapy), Intravitreal Melphalan
Study Phase: Phase 2
Pan-genome Analysis of Neuroblastoma by Comparative Genomic Hybridization and Correlation With Pathology for the Diagnostic and the Prognostic Classification
Pan-genome Analysis of Neuroblastoma by Comparative Genomic Hybridization and Correlation With Pathology for the Diagnostic and the Prognostic Classification
Enrollment Status: Completed
Publish Date: December 01, 2023
Intervention Type: Procedure
Study Phase: Not Applicable
Phase 2 Study of a Reduced-toxicity Myeloablative Conditionning Regimen Using Fludarabine and Full Doses of iv Busulfan in Pediatric Patients Not Eligible for Standard Myeloablative Conditioning Regimens
Phase 2 Study of a Reduced-toxicity Myeloablative Conditionning Regimen Using Fludarabine and Full Doses of iv Busulfan in Pediatric Patients Not Eligible for Standard Myeloablative Conditioning Regimens
Enrollment Status: Completed
Publish Date: April 05, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

45 Total Publications

Inhibition of the CXCR4/PLC Signaling Increases Dexamethasone-Induced Sensitivity by Activating the Mitochondrial Apoptotic Pathway in B-Cell Acute Lymphoblastic Leukemia.
Inhibition of the CXCR4/PLC Signaling Increases Dexamethasone-Induced Sensitivity by Activating the Mitochondrial Apoptotic Pathway in B-Cell Acute Lymphoblastic Leukemia.
Journal: International journal of molecular sciences
Published: March 08, 2025

Frequently Asked Questions about Jean-pierre P. Vannier

Is Jean-pierre P. Vannier a top-rated expert for Sideroblastic Anemia?

MediFind is an objective health platform that identifies experts based on real-world data. Jean-pierre P. Vannier is classified as an Advanced expert for Sideroblastic Anemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jean-pierre P. Vannier participate in research or clinical trials?

Yes. Jean-pierre P. Vannier has published 45 articles and abstracts on conditions like Sideroblastic Anemia. You can view a list of Jean-pierre P. Vannier's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Vannier's expertise for a condition
ConditionClose
      View All 12 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile